Medigen Vaccine, Dynavax begin phase II trial for subunit COVID-19 vaccine

By The Science Advisory Board staff writers

January 25, 2021 -- Medigen Vaccine Biologics and Dynavax Technologies have dosed the first participant in a phase II clinical trial evaluating Medigen's COVID-19 vaccine candidate, MVC-COV1901, a subunit vaccine with a recombinant spike-2P antigen adjuvanted with Dynavax's CpG 1018.

The spike-2P antigen is a trimeric and prefusion stable recombinant protein developed by the U.S. National Institutes of Health (NIH). Medigen has obtained the global technology license for spike-2P from the U.S. Vaccine Research Center at NIH. The new study is based on positive phase I interim data demonstrating a good safety profile and encouraging immunogenicity of the vaccine candidate.

The phase II trial, located in Taiwan, is a randomized, double-blinded, multicenter trial expected to enroll 3,700 healthy subjects, 20 years of age and older. It will evaluate safety and immunogenicity with a dosing regiment of two intramuscularly administered doses one month apart.

Dynavax partners on Valneva's SARS-CoV-2 vaccine candidate
Dynavax will supply its CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001, as part of a commercial partnership.
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...
Dynavax, Clover partner for protein-based COVID-19 vaccine
A new research collaboration between Dynavax Technologies and Clover Biopharmaceuticals aims to develop a vaccine candidate to prevent COVID-19. The partnership,...

Copyright © 2021

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter